2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Computational Biology, Emerging Technologies, Profiling, Treatment Considerations, Drug Development, Biological Therapies, Antibody Therapy, Biological Processes, Pathogenesis, Hematopoiesis, Immune Mechanism, Molecular Biology, Multi-Systemic Interactions, Clinical Practice (Health Services and Quality), Practice Models, Quality Improvement, Quality of Care, Value, Diseases, Genetic Disorders, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Trait, Thalassemia, Infectious Diseases, Viral, Research, Fundamental Science, Translational Research, Clinical Research, Health Disparities Research, Study Population, Human, Adult, Pediatric, Animal Model
PAPER

4661 Regenerative stress is associated with increased hematopoietic stem cell mutational burden, clonal hematopoiesis and myelodysplasia in sickle cell disease mice

Mengna Chi, PhD, Ammar Husami, MS2, Fabienne Lucas3, Shristi Khanal, MS4, Tahereh Sara Setayesh, PhD5, Zhenqi Zhu, PhD6, Harsimran Kaur, MD7, Anifat Tijani, MS8, Jing Chen9, Wenying Zhang, MD, PhD10, Punam Malik, MD11
1 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
2 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
3 University of Washington, Washington, United States
4 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
5 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
6 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
7 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
8 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
9 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
10 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States
11 Cincinnati Children's Hospital Medical Center Cincinnati, United States, Cincinnati, Ohio, United States

Introduction: Sickle cell disease affects millions globally, causes significant lifelong morbidity and early death. With improved treatment, patients are surviving to adulthood. An increased risk of myelodysplastic syndrome (MDS) and hematological malignancy (HM) is becoming evident both in SCD population-based studies and gene therapy/allogeneic transplants. The specific pathobiology that predisposes to MDS/HM is necessary to address. We modeled clonal hematopoiesis (CH) and MDS in the humanized SCD mice to study the underlying mechanisms.

Methods: Humanized Townes SS (hα/hα::hβS/βS) mice and their normal AA (hα/hα::hβA/hβA) counterparts were aged to 1 year-of-age (yo). Peripheral blood (PB) was assessed via CBCs, morphology and flow cytometry. Mice were sacrificed at 1-yo for histopathology and deep sequencing on bone marrow (BM) cells. SS/AA BM cells (CD5.2) were also serially transplanted into C57Bl/6-By/J (CD45.1) primary (3 months) and secondary recipients (6 months) and mice with >95% donor chimerism evaluated. Whole-exome sequencing (WES; 400X depth) and targeted deep sequencing (TDS; 30,000X depth, using a custom panel of 450 genes associated with HM, CH and MDS in mice and humans) was performed. Germline DNA was sequenced concurrently to exclude germline variants.

Results: WES of BM from 1-yo SS mice showed increased single nucleotide variant (SNVs), higher transition mutations, including enrichment of C>T mutations, characteristically seen in aged mice/humans compared to 1-yo AA controls. PB from age-, sex- matched AA (n=25) and SS (n=35) showed higher myeloid- and lower T- and B- lymphoid cells in SS mice at 6 months and 1 yo (P<0.0001), in contrast to a constant distribution of lineages in AA mice. This aging-like phenotype occurs with regenerative stress. Indeed, a higher proportion cycling long-term HSC were present in SS mice than age- and sex-matched AA mice (n=6).

We studied whether this stressed hematopoietic environment predisposed to CH and MDS. A high proportion of SS mice developed abnormal hematopoiesis (CD45dim, CD33+CD11bdim/neg myeloid- and CD19dim lymphoid populations) in PB (SS-a). SS-a mice analysed showed tri-lineage dysplasia or ‘MDS-like’ morphology in PB and by BM histology. TDS on BM from SS-a vs SS-t (typical myeloid-biased hematopoiesis) mice showed that majority of SS-a mice had variants at >1% VAF. This phenomenon was rare in SS-t mice. The top 20 mutated genes with the highest VAF, all implicated in development of MDS/leukaemia, were present in the SS-a mice and were nearly absent in SS-t mice.  

Further regenerative stress was imposed on 1-yo SS and AA BM via serial HSCT. TDS on BM DNA pre-HSCT and post-HSCT showed that non-synonymous somatic variants were higher in SS- compared to AA BM cells pre-HSCT and further increased post-HSCT. Using ≥2% VAF threshold for analysing CH showed remarkably higher CH post-HSCT in SS BM, increasing from 39 variants pre-HSCT to 499 post-HSCT vs. no significant increase in AA BM. CH mutations mostly occurred de novo in post-HSCT SS BM.

To ensure that this was not from the small residual recipient ByJ cells post irradiation for HSCT, another set of HSCT was performed. BM was enriched for CD45.1 cells. TDS showed a reduction of VAF of somatic mutations after CD45.1-enriched fraction compared to WBM. Had the clones arisen from CD45.1+ cells, they would be at much higher VAF post-CD45.1 enrichment.

Notably, most somatic variants and the genes they affected were uniquely detected in BM of SS mice post-HSCT, with 713 new variants across 231 genes. CH mutations in Gata2, Idh1, Crebbp, Pclo, Sf3b1, Asxl1, Tet1, and Dnmt3a were primarily unique to SS mice post-HSCT. These are frequently observed in humans and associated with an increased risk of de novo MDS and AML, but were nearly absent in AA mice implicating an interaction between regenerative stress, an ‘ageing-like’ HSPC population and conceivably the underlying SCD pathophysiology in promoting clonal selection.

Conclusion: Our findings demonstrate that SS mice had prematurely ‘ageing-like’ phenotype from regenerative stress, resulting in a myeloid-biased hematopoiesis, a high mutational burden in HSPCs, and accumulation of transition mutations. This was associated with development of tri-lineage dysplasia in some animals. Imposition of proliferative/regenerative stress on HSC via serial HSCT resulted in HSPC clones with deleterious mutations in genes associated with MDS/HM.

Shristi Khanal, MS: No relevant conflicts of interest to declare.